Literature DB >> 17571855

Screening and sequencing of glycated proteins by neutral loss scan LC/MS/MS method.

Himanshu S Gadgil1, Pavel V Bondarenko, Michael J Treuheit, Da Ren.   

Abstract

Nonenzymatic protein glycation is caused by a Schiff's base reaction between the aldehyde groups of reducing sugars and the primary amines of proteins. A reversed-phase liquid chromatography method followed by a neutral loss scan mass spectrometric method was developed for the screening of glycation in proteins. The neutral loss scan was based on a unique sugar moiety neutral loss (-162 Da) that we observed in the fragmentation spectra of glycated peptides on Q-Tof type mass spectrometers. The collision energy was optimized for this neutral loss using a glycated synthetic peptide, and 20 eV was found to be the optimum collision energy. The neutral loss scan experiment was composed of two segments. In the first segment, the glycated peptides were identified based on the signature neutral loss of 162 Da when the collision energy was elevated to 20 eV. In the second segment, the glycated peptides were selected as the parent ions and fragmented at higher collision energy to break the peptide bonds. The fragmentation spectra of the selected glycated peptides revealed both the amino acid sequences and the sites of glycation. This neutral loss scan method was used to study the glycation in human serum albumin (HSA). The glycation sites in HSA were identified based on the retention time shift of glycated peptides, the mass accuracy from the MS scan, the signature neutral loss, and MS/MS information. Using this method, we were able to identify that 31 lysine residues were partially glycated from the glycated HSA sample, which has a total of 59 lysine residues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17571855     DOI: 10.1021/ac070619k

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  15 in total

Review 1.  Proteomic identification of carbonylated proteins and their oxidation sites.

Authors:  Ashraf G Madian; Fred E Regnier
Journal:  J Proteome Res       Date:  2010-08-06       Impact factor: 4.466

2.  Mass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseases.

Authors:  Xin Wei; Lingjun Li
Journal:  Int J Clin Exp Pathol       Date:  2008-06-20

Review 3.  Recent topics in chemical and clinical research on glycated albumin.

Authors:  Yuki Ueda; Hideyuki Matsumoto
Journal:  J Diabetes Sci Technol       Date:  2015-01-21

4.  Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects.

Authors:  Qibin Zhang; Matthew E Monroe; Athena A Schepmoes; Therese R W Clauss; Marina A Gritsenko; Da Meng; Vladislav A Petyuk; Richard D Smith; Thomas O Metz
Journal:  J Proteome Res       Date:  2011-06-10       Impact factor: 4.466

Review 5.  Photo-Degradation of Therapeutic Proteins: Mechanistic Aspects.

Authors:  Christian Schöneich
Journal:  Pharm Res       Date:  2020-02-03       Impact factor: 4.200

Review 6.  An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus.

Authors:  Km Neelofar; Jamal Ahmad
Journal:  Glycoconj J       Date:  2017-08-15       Impact factor: 2.916

7.  Multi-Stage Mass Spectrometry Analysis of Sugar-Conjugated β-Turn Structures to be Used as Probes in Autoimmune Diseases.

Authors:  Chiara Giangrande; Nicolas Auberger; Cédric Rentier; Anna Maria Papini; Jean-Maurice Mallet; Solange Lavielle; Joëlle Vinh
Journal:  J Am Soc Mass Spectrom       Date:  2016-01-04       Impact factor: 3.109

8.  Crystal structure of equine serum albumin in complex with cetirizine reveals a novel drug binding site.

Authors:  Katarzyna B Handing; Ivan G Shabalin; Karol Szlachta; Karolina A Majorek; Wladek Minor
Journal:  Mol Immunol       Date:  2016-02-17       Impact factor: 4.407

9.  Analysis of non-enzymatically glycated peptides: neutral-loss-triggered MS(3) versus multi-stage activation tandem mass spectrometry.

Authors:  Qibin Zhang; Vladislav A Petyuk; Athena A Schepmoes; Daniel J Orton; Matthew E Monroe; Feng Yang; Richard D Smith; Thomas O Metz
Journal:  Rapid Commun Mass Spectrom       Date:  2008-10       Impact factor: 2.419

Review 10.  A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease.

Authors:  Qibin Zhang; Jennifer M Ames; Richard D Smith; John W Baynes; Thomas O Metz
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.